Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)